News

The companies, along with 12 other global drug manufacturers have received letters from the US House Committee on Oversight and Government Reform Ranking Member Elijah Cummings and Senator

Striverdi Respimat has been prescribed as a once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema The

The rectal foam is a rectally administered corticosteroid that overcomes treatment limitations related with currently approved therapies which are often ineffective due to insufficient distribution of active drug

dCellVax uses the patient’s own immune cells to attack the tumor and its success in the proposed trial is expected to pave the way for expanded use of

RDIM utilizes an orally disintegrating, controlled release, taste-masked pharmaceutical composition that can withstand compression forces associated with standard tableting technology, allowing for a drug to be incorporated into

Aciex is a private, US-based ophthalmic development pharmaceutical company with a strong near-term pipeline of therapeutics addressing major segments of the ophthalmic market, including allergy and inflammation. On

The company received this award after the successful completion of the Phase I contract, which studied BLZ-100 in canine patients with multiple tumor types. The award will fund

Poorly soluble drug candidates are difficult to administer even as intravenous drugs. Low concentrations may limit therapeutic response and require long infusion periods which are poorly tolerated and

Teva expects to complete the NDA submission by the end of 2014. CEP-33237 is an investigational, 12-hour, acetaminophen-free, formulation of extended-release (ER) hydrocodone for the management of pain